Lunai Bioworks Inc. (RENB) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
Address
2080 Century Park East
Los Angeles, CA 90067
United States of America (the)
Phone
305 918 1980
Website
Sector
Healthcare
Industry
Biotechnology
Employees
25
First IPO Date
February 07, 2018
| Name | Title | Pay | Year Born |
| David H. Weinstein | Chief Executive Officer & Director | 0 | 1961 |
| Francois Binette | Executive Vice President for Research & Development | 402,500 | 1964 |
| Serhat Gümrükcü | Co-Founder & Inventor | 0 | N/A |
| Greg Duczynski | Senior Vice President for Clinical Operations | 0 | N/A |
| Nathen Fuentes | Chief Financial Officer | 0 | 1983 |
Lunai Bioworks, Inc. functions as a pre-clinical stage biotechnology enterprise, concentrating its efforts on pioneering genetically modified cell and immunotherapeutic platforms. These advanced technologies are aimed at providing treatments for a range of infectious diseases and oncological conditions. The company's development pipeline features several candidates, specifically ENOB-HV-01, ENOB-HV-11, ENOB-HV-12, ENOB-DB-01, ENOB-DC-01, ENOB-DC-11, and ENOB-DC-21. Founded on January 18, 2011, by Rene Sindlev and Serhat Gumrukcu, Lunai Bioworks maintains its corporate base in Los Angeles, California.